Skip to main content
Maxwell Witt, MD, Infectious Disease, Aurora, CO

Maxwell Witt MD


Infectious Disease Fellow at CU Anschutz

Join to View Full Profile
  • 12700 E. 19th Avenue – B-168Research Complex 2 BldgAurora, CO 80045

Dr. Witt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Maxwell Witt is an infectious disease specialist based in Aurora, CO. He is currently pursuing a fellowship in infectious disease at the University of Colorado, having completed his residency in internal medicine at the University of New Mexico School of Medicine. He graduated from the University of Michigan Medical School in 2020 and holds a BA in Public Health from the University of California, Berkeley. His publication record includes impactful research on pertussis vaccination, hepatitis C treatment, and organ transplant, with several of his works receiving citations in the field.

Education & Training

  • University of Colorado
    University of ColoradoFellowship, Infectious Disease, 2023 - 2025
  • University of New Mexico School of Medicine
    University of New Mexico School of MedicineResidency, Internal Medicine, 2020 - 2023
  • University of Michigan Medical School
    University of Michigan Medical SchoolClass of 2020
  • University of California, Berkeley
    University of California, BerkeleyBA, Public Health, 2010 - 2014

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 2023 - 2027
  • NM State Medical License
    NM State Medical License 2020 - 2023
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Abstracts/Posters

  • Real-Word Effectiveness of 8, 12 and 24 Weeks Ledipasvir (LDV)/Sofosbuvir (SOF)-Based Therapy for Hepatitis C Virus (HCV) Genotype 1: Analysis in a Large Integrated He...
    J Lai, M Witt, D Witt, EASL 2016
  • BRUGADA SYNDROME IN SETTING OF KRATOM USE
    Fahad Hussain, Max Witt, Carmel Moazez, Jerome P. Yatskowitz, Paul Andre, Michael Bestawros, American College of Cardiology, 3/2023

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: